Takeda executives were accused of ignoring or down-playing worries about the drug's cancer links before it was sold in the US; they also mislead health regulators about the risks.
Takeda's Experimental Drug More Effective in Lowering Blood Sugar Levels Than Generics
A study sponsored by Takeda Pharmaceutical has found that its experimental diabetes drug was more effective than older generic medicine
A study sponsored by Takeda Pharmaceutical has found that its experimental diabetes drug was more effective than older generic medicine
Last year a federal jury in Louisiana ordered Takeda and US-based Eli Lilly & Co. to pay a combined $9.0 billion in damages to a patient who accused Actos had caused his bladder cancer. This payout was later cut to $36.8 million. Eli Lilly was Takeda’s US marketing and sales partner until 2006.
Source-Medindia
FDA Approves Takeda's Anti-Hypertensive Drug
The US Food and Drug Administration has given its approval for Takeda Pharmaceutical to market its hypertension drug in the country.
The US Food and Drug Administration has given its approval for Takeda Pharmaceutical to market its hypertension drug in the country.
FDA Approves Generic Version of Actos for Type 2 Diabetes
The first generic version of type 2 diabetes drug, Actos has been approved by the US Food and Drug Administration.
The first generic version of type 2 diabetes drug, Actos has been approved by the US Food and Drug Administration.
Claim That Raw Milk Reduces Lactose Intolerance Fails to Materialize in Study
There is little difference in digestibility between raw milk and pasteurized milk, a pilot study from the Stanford University School of Medicine shows.
There is little difference in digestibility between raw milk and pasteurized milk, a pilot study from the Stanford University School of Medicine shows.
